Lanxess falls after FY sales miss, sees no improvement in H1

LANXESS AG

19/03/2026 08:14

** Shares in Lanxess LXSG.DE fall 9% after the speciality chemicals maker posted its FY sales below expectations and expected no improvement in its business in H1

** Lanxess posts FY revenue of 5.67 billion euros ($6.49 billion), down 10.9% from 6.36 billion euros a year earlier, and below analyst's average forecast of 5.72 billion euros in a company-provided poll

** The company foresees its business not to pick up before the second half of 2026 at the earliest

** "Weaker than expected Q1 indications may result in some share underperformance this morning," J.P. Morgan says

** Lanxess expects FY EBITDA pre-exceptionals of 450-550 million euros for 2026, compared with 510 million euros last year

** The stock, which has lost 30.7% including today's session, hits the bottom of Germany's mid-cap index .MDAXI

($1 = 0.8732 euros)

 (Reporting by Ozan Ergenay)

 ((ozan.ergenay@thomsonreuters.com))